SEC Contract Filing

Filing Date: 2018-06-08

Document Content:
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>exhibit103debenture.htm
<DESCRIPTION>MATERIAL CONTRACTS
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
NEITHER THIS DEBENTURE NOR THE SECURITIES INTO WHICH THIS DEBENTURE
IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE.
THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#x201C;<font style="text-decoration: underline">SECURITIES
ACT</font>&#x201D;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-variant: small-caps; font-family: Times New Roman; font-size: 16px">
CANTABIO PHARMACEUTICALS INC.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-variant: small-caps; font-family: Times New Roman; font-size: 13px">
Secured Convertible Debenture</font></div>
<div style="text-align: justify"><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Principal Amount:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Original Issuance Date:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Debenture Number:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">FOR VALUE RECEIVED,</font> CANTABIO
PHARMACEUTICALS INC., a Delaware corporation (the "<font style="text-decoration: underline">Company</font>"), hereby promises to
pay to the order of YA II PN, Ltd., or its registered assigns (the
"<font style="text-decoration: underline">Holder</font>") the
amount set out above as the Principal Amount (as reduced pursuant
to the terms hereof pursuant to redemption, conversion or
otherwise, the "<font style="text-decoration: underline">Principal</font>") when due, whether
upon the Maturity Date (as defined below), acceleration, redemption
or otherwise (in each case in accordance with the terms hereof) and
to pay interest ("<font style="text-decoration: underline">Interest</font>") on any outstanding
Principal at the applicable Interest Rate from the date set out
above as the Original Issuance Date (the "<font style="text-decoration: underline">Issuance Date</font>") until the same
becomes due and payable, whether upon an Interest Date (as defined
below), the Maturity Date or acceleration, conversion, redemption
or otherwise (in each case in accordance with the terms hereof).
This Secured Convertible Debenture (including all debentures issued
in exchange, transfer or replacement hereof, this "<font style="text-decoration: underline">Debenture</font>") was issued pursuant
to the Securities Purchase Agreement dated , (the
&#x201C;<font style="text-decoration: underline">Securities Purchase
Agreement</font>&#x201D;) between the Company and the Buyers listed
on the Schedule of Buyers attached thereto. Certain capitalized
terms used herein are defined in Section 16.</font></div>
<div style="text-align: justify"><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="text-decoration: underline; font-family: Times New Roman; font-size: 13px">GENERAL
TERMS</font></div>
<div style="text-align: justify"><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; text-indent: 144px">
<font style="font-family: Times New Roman; font-size: 13px">(a)</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px"><font style="text-decoration: underline">Maturity Date</font>. The
"<font style="text-decoration: underline">Maturity Date</font>"
shall be , as may be extended at the option of the
Holder.</font></div>
<div style="text-align: justify"><font style="font-family: Times New Roman; font-size: